已收盘 02-06 16:00:00 美东时间
-0.060
-1.13%
今日重点评级关注:Needham:维持Autolus Therapeutics"买入"评级,目标价从10美元升至11美元;BTIG:维持Praxis Precision Medicine"买入"评级,目标价从507美元升至843美元
2025-12-30 10:04
Northland Capital Markets analyst Robert Brooks initiates coverage on 1stdibs.com (NASDAQ:DIBS) with a Market Perform rating and announces Price Target of $7.
2025-12-29 22:25
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据1stdibs业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **收入表现:** - 净收入达到2,280万美元,同比增长9%,这是连续第三个季度实现同比增长,也是自2021年以来的最高增长率 - 商品交易总额(GMV)为9,450万美元,同比增长9%,创三年来最快增长速度 - 毛利润为1,650万美元,同比增长10% **盈利能力:** - 毛利率达到72%,同比提升1个百分点 - 调整后EBITDA亏损160万美元,去年同期亏损170万美元 - 调整后EBITDA利润率为负7%,同比改善1个百分点 **成本控制:** - 运营费用
2025-12-12 12:13
1stdibs.com (NASDAQ:DIBS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the
2025-11-07 20:02
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
2025-11-07 19:11
Gainers Yatra Online (NASDAQ:YTRA) stock rose 19.7% to $1.08 during Monday's p...
2025-08-11 20:08
Earnings Call Insights: 1stdibs.Com, Inc. (DIBS) Q2 2025 Management View CEO David S. Rosenblatt stated that "the second quarter demonstrated continued resilience amidst a dynamic market with GMV and ...
2025-08-07 10:58
1Stdibs.Com, Inc. (($DIBS)) has held its Q1 earnings call. Read on for the main...
2025-05-10 08:47
William Blair analyst Ralph Schackart maintained a Buy rating on 1stdibs.com (D...
2025-05-09 22:45